Your browser doesn't support javascript.
loading
Rituximab: a benchmark in the development of chemotherapy-free treatment strategies for follicular lymphomas.
Karmali, R; Kimby, E; Ghielmini, M; Flinn, I W; Gordon, L I; Zucca, E.
Affiliation
  • Karmali R; Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA. Electronic address: reem.karmali@northwestern.edu.
  • Kimby E; Division of Hematology, Department of Medicine at Huddinge, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden, Switzerland.
  • Ghielmini M; IOSI/Oncology Institute of Southern Switzerland, Bern, Switzerland; Group for Clinical Cancer Research, Bern, Switzerland; Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, USA; Tennessee Oncology, PLLC, Nashville, USA.
  • Gordon LI; Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.
  • Zucca E; IOSI/Oncology Institute of Southern Switzerland, Bern, Switzerland; Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland; IELSG/International Extranodal Lymphoma Study Group, Bern, Switzerland.
Ann Oncol ; 29(2): 332-340, 2018 02 01.
Article in En | MEDLINE | ID: mdl-29206891
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Rituximab / Antineoplastic Agents, Immunological Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Rituximab / Antineoplastic Agents, Immunological Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: